BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGNX
3176
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $98.8K | ﹤0.01% |
19,408
+5,941
| +44% | +$31.4K |
|
|
LBAI
3177
DELISTED
Lakeland Bancorp Inc
LBAI
| $98.6K | ﹤0.01% |
5,671
-1,665
| -23% | -$27.4K |
|
3178
Barrett Business Services
BBSI
$800M
| $98.4K | ﹤0.01% |
4,352
-260
| -6% | -$5.76K |
|
|
PTR
3179
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $98.4K | ﹤0.01% |
1,955
+115
| +6% | +$5.66K |
|
|
DX
3180
Dynex Capital
DX
$3.23B
| $98.3K | ﹤0.01% |
5,803
+2,089
| +56% | +$33.7K |
|
|
LTRPA
3181
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $97.8K | ﹤0.01% |
13,302
+103
| +0.8% | +$829 |
|
|
NVO
3182
Novo Nordisk
NVO
$205B
| $97.6K | ﹤0.01% |
3,372
+1,246
| +59% | +$34.5K |
|
|
CHL
3183
CALL
DELISTED
China Mobile Limited
CHL
| $97.2K | ﹤0.01% |
23
+14
| +156% | +$565 |
|
3184
Ameresco
AMRC
$1.47B
| $97.1K | ﹤0.01% |
5,548
+2,360
| +74% | +$37.1K |
|
|
CNR
3185
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $97K | ﹤0.01% |
11,394
+4,374
| +62% | +$30.8K |
|
3186
Gossamer Bio
GOSS
$83.3M
| $96.9K | ﹤0.01% |
6,201
-758
| -11% | -$15.3K |
|
3187
Alaunos Therapeutics
TCRT
$4.86M
| $96.8K | ﹤0.01% |
137
-46
| -25% | -$31.7K |
|
3188
Tenaris
TS
$26.6B
| $96.8K | ﹤0.01% |
4,275
-1,784
| -29% | -$38.4K |
|
3189
Applied Optoelectronics
AAOI
$11B
| $96.8K | ﹤0.01% |
8,145
+8
| +0.1% | +$85 |
|
|
EGIO
3190
DELISTED
Edgio, Inc. Common Stock
EGIO
| $96.5K | ﹤0.01% |
591
+153
| +35% | +$24.2K |
|
|
CRCM
3191
DELISTED
CARE.COM, INC.
CRCM
| $96.3K | ﹤0.01% |
6,408
+2,906
| +83% | +$34.9K |
|
3192
Dorian LPG
LPG
$1.95B
| $96.2K | ﹤0.01% |
6,214
+1,755
| +39% | +$23.1K |
|
|
CNR
3193
Core Natural Resources Inc
CNR
$4.64B
| $96K | ﹤0.01% |
6,616
+693
| +12% | +$9.57K |
|
3194
Miller Industries
MLR
$640M
| $95.9K | ﹤0.01% |
2,582
+798
| +45% | +$28.1K |
|
3195
Seneca Foods Class A
SENEA
$1.31B
| $95.5K | ﹤0.01% |
2,342
+1,196
| +104% | +$43.1K |
|
3196
York Water
YORW
$536M
| $95.3K | ﹤0.01% |
2,067
-9
| -0.4% | -$395 |
|
|
LGF.B
3197
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $95K | ﹤0.01% |
9,568
+3,285
| +52% | +$28.3K |
|
3198
NN Inc
NNBR
$298M
| $95K | ﹤0.01% |
10,269
+3,555
| +53% | +$28.5K |
|
3199
Bar Harbor Bankshares
BHB
$681M
| $94.8K | ﹤0.01% |
3,735
+1,272
| +52% | +$32.4K |
|
3200
Vera Bradley
VRA
$94.7M
| $94.1K | ﹤0.01% |
7,974
+4,498
| +129% | +$49.9K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.